Clinicopathologic Factors Associated with Mismatch Repair Status Among Filipino Patients with Young-Onset Colorectal Cancer

References

• Ferlay J, Soerjomataram I, Ervik M, et al., Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer; Lyon, France: 2013. Available from: http://globocan.iarc.fr;. Accessed 218, 2021.
   Google Scholar
• Laudico AV, Medina V, Mirasol-Lumague MR, et al. 2010 Philippine Cancer Facts and Estimates. Manila: Philippine Cancer Society, Inc; 2010.
   Google Scholar
• Laudico AV, Mirasol-Lumague MR, Medina V, Mapua CA, Valenzuela FG, Pukkala E. 2015 Philippine Cancer Facts and Estimates. Manila: Philippine Cancer Society, Inc; 2015.
   Google Scholar
• Kaw LL, Punzalan CK, Crisostomo AC, Bowyer MW, Wherry DC. Surgical pathology of colorectal cancer in Filipinos: implications for clinical practice. J Am Coll Surg. 2002;195:188–195. doi:10.1016/S1072-7515(02)01186-912168965
   PubMed Web of Science ®Google Scholar
• Chang RL, Roxas MF, Asprer JM. Colorectal cancer in the young: a five-year review of cases. Philipp J Surg Spec. 2003;58(1):32–35.
   Google Scholar
• Nguyen LH, Liu PH, Zheng X, et al. Sedentary behaviors, TV viewing time, and risk of young-onset colorectal cancer. JNCI Cancer Spectr. 2019;2:pky073. doi:10.1093/jncics/pky073
   Web of Science ®Google Scholar
• Grady WM. CIMP and colon cancer gets more complicated. Gut. 2007;56(11):1498–1500. doi:10.1136/gut.2007.12573217938428
   PubMed Web of Science ®Google Scholar
• Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn. 2008;10:13–27. doi:10.2353/jmoldx.2008.07008218165277
   PubMed Web of Science ®Google Scholar
• Hashmi AA, Ali R, Hussain ZF, et al. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters. World J Surg Oncol. 2017;15:116. doi:10.1186/s12957-017-1158-828651545
   PubMed Web of Science ®Google Scholar
• Kawakami H, Zaanan A, Sinicrope FA. Microsatellite instability testing and its role in the management of colorectal cancer. Curr Treat Options Oncol. 2015;16:30. doi:10.1007/s11864-015-0348-226031544
   PubMed Web of Science ®Google Scholar
• Smith C, Butler JA. Colorectal cancer in patients younger than 40 years of age. Dis Colon Rectum. 1989;32:843–846. doi:10.1007/BF025545522791769
   PubMed Web of Science ®Google Scholar
• De la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol. 2010;28:3380–3387. doi:10.1200/JCO.2009.27.065220516444
   PubMed Web of Science ®Google Scholar
• Loughrey MB, McGrath J, Coleman HG, et al. Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series. Histopathology. 2020. doi:10.1111/his.14233
   Web of Science ®Google Scholar
• Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008;18:85–98. doi:10.1038/cr.2007.11518157157
   PubMed Web of Science ®Google Scholar
• Hall G, Clarkson A, Shi A, et al. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma. Pathology. 2010;42:409–413.20632815
   PubMed Web of Science ®Google Scholar
• Gatalica Z, Vranic S, Xiu J, Swensen J, Reddy S. High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine. Fam Cancer. 2016;15:405–412. doi:10.1007/s10689-016-9884-626875156
   PubMed Web of Science ®Google Scholar
• Greenson JK, Huang SC, Herron C, et al. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 2009;33:126–133. doi:10.1097/PAS.0b013e31817ec2b118830122
   PubMed Web of Science ®Google Scholar
• Lee J, Xiao YY, Sun YY, et al. Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients. BMC Cancer. 2017;17:843. doi:10.1186/s12885-017-3799-y29237405
   PubMed Web of Science ®Google Scholar
• Baran B, Ozupek NM, Tetik NY, Acar E, Bekcioglu O, Baskin Y. Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterol Res. 2018;11:264–273.
   PubMed Web of Science ®Google Scholar
• Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158:527–535. doi:10.1016/S0002-9440(10)63994-611159189
   PubMed Web of Science ®Google Scholar
• Overman MJ, Lonardi S, Wong KY, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36:773–779. doi:10.1200/JCO.2017.76.990129355075
   PubMed Web of Science ®Google Scholar
• Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372:2509–2520. doi:10.1056/NEJMoa150059626028255
   PubMed Web of Science ®Google Scholar
• Stigliano V, Sanchez-Mete L, Martayan A, Anti M. Early-onset colorectal cancer: a sporadic or inherited disease? World J Gastroenterol. 2014;2014(20):12420. doi:10.3748/wjg.v20.i35.12420
   Web of Science ®Google Scholar
• Uy GB, Kaw LL, Punzalan CK, et al. Clinical and molecular biologic characteristics of early-onset versus late-onset colorectal carcinoma in Filipinos. World J Surg. 2004;28:117–123. doi:10.1007/s00268-003-7281-414708047
   PubMed Web of Science ®Google Scholar
• Dozois EJ, Boardman LA, Suwanthanma W, et al. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine. 2008;87:259. doi:10.1097/MD.0b013e318188135418794708
   PubMed Web of Science ®Google Scholar
• Sargent DJ, Shi Q, Yothers G, et al. Prognostic impact of deficient mismatch repair (dMMR) in 7,803 stage II/III colon cancer (CC) patients (pts): a pooled individual patient data analysis of 17 adjuvant trials in the ACCENT database. J Clin Oncol. 2014;32:5s. doi:10.1200/jco.2014.32.15_suppl.3507
   PubMed Web of Science ®Google Scholar
• Lee CT, Chow NH, Chen YL, et al. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer. Pathol Res Pract. 2020;217:153288. doi:10.1016/j.prp.2020.15328833276219
   PubMed Web of Science ®Google Scholar
• Jung J, Kang Y, Lee YJ, et al. Comparison of the mismatch repair system between primary and metastatic colorectal cancers using immunohistochemistry. J Pathol Transl Med. 2017;51:129–136. doi:10.4132/jptm.2016.12.0928192899
   PubMed Web of Science ®Google Scholar
• Pearlman R, Markow M, Knight D, et al. Two-stain immunohistochemical screening for Lynch syndrome in colorectal cancer may fail to detect mismatch repair deficiency. Mod Pathol. 2018;31:1891–1900.29967423
   PubMed Web of Science ®Google Scholar
• Roth RM, Haraldsdottir S, Hampel H, Arnold CA, Frankel WL. Discordant mismatch repair protein immunoreactivity in Lynch syndrome-associated neoplasms: a recommendation for screening synchronous/metachronous neoplasms. Am J Clin Pathol. 2016;146:50–56. doi:10.1093/ajcp/aqw06727357288
   PubMed Web of Science ®Google Scholar